Recordati Industria Chimica e Farmaceutica S.p.A. (LON:0KBS)

London flag London · Delayed Price · Currency is GBP · Price in EUR
54.33
+0.93 (1.73%)
At close: Jul 1, 2025
11.46%
Market Cap 9.53B
Revenue (ttm) 2.02B
Net Income (ttm) 349.65M
Shares Out n/a
EPS (ttm) 1.67
PE Ratio 27.25
Forward PE 16.39
Dividend 1.07 (1.98%)
Ex-Dividend Date May 19, 2025
Volume 7,362
Average Volume 15,416
Open 53.50
Previous Close 53.40
Day's Range 53.20 - 54.30
52-Week Range 44.04 - 60.95
Beta 0.52
RSI 49.57
Earnings Date Jul 29, 2025

About LON:0KBS

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops REC 0545 for acute decompensation in maple syrup urine diseases; Isturia for endogenous Cushing’s syndrome; Cystadrops for corneal cystine crystal deposits; Carbaglu for hyperammonemia due ... [Read more]

Industry Pharmaceutical Preparations
Founded 1926
Employees 4,583
Stock Exchange London Stock Exchange
Ticker Symbol 0KBS
Full Company Profile

Financial Performance

In 2024, LON:0KBS's revenue was 2.34 billion, an increase of 12.45% compared to the previous year's 2.08 billion. Earnings were 416.51 million, an increase of 7.01%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.